These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36495674)
1. Predictors of early heart failure rehospitalization among older adults with preserved and reduced ejection fraction: A review and derivation of a conceptual model. Sue-Ling CB; Jairath N Heart Lung; 2023; 58():125-133. PubMed ID: 36495674 [TBL] [Abstract][Full Text] [Related]
2. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction. Goyal P; Loop M; Chen L; Brown TM; Durant RW; Safford MM; Levitan EB J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686028 [TBL] [Abstract][Full Text] [Related]
3. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L; Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337 [TBL] [Abstract][Full Text] [Related]
5. Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction. Tay WT; Teng TK; Simon O; Ouwerkerk W; Tromp J; Doughty RN; Richards AM; Hung CL; Qin Y; Aung T; Anand I; Lam CSP; J Am Heart Assoc; 2021 Nov; 10(22):e021414. PubMed ID: 34666509 [TBL] [Abstract][Full Text] [Related]
6. Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction. Farasat SM; Bolger DT; Shetty V; Menachery EP; Gerstenblith G; Kasper EK; Najjar SS Am J Cardiol; 2010 Jan; 105(2):229-34. PubMed ID: 20102924 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction. Setoguchi M; Hashimoto Y; Sasaoka T; Ashikaga T; Isobe M Heart Vessels; 2015 Sep; 30(5):595-603. PubMed ID: 24935218 [TBL] [Abstract][Full Text] [Related]
8. Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction. Park J; Zhong X; Babaie Sarijaloo F; Wokhlu A Clin Cardiol; 2022 Apr; 45(4):370-378. PubMed ID: 35077583 [TBL] [Abstract][Full Text] [Related]
9. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort. Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939 [TBL] [Abstract][Full Text] [Related]
11. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225 [TBL] [Abstract][Full Text] [Related]
12. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction. Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180 [TBL] [Abstract][Full Text] [Related]
15. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. Sartipy U; Dahlström U; Fu M; Lund LH JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451 [TBL] [Abstract][Full Text] [Related]
16. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications. Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874 [TBL] [Abstract][Full Text] [Related]
17. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110 [TBL] [Abstract][Full Text] [Related]
18. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort. Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929 [TBL] [Abstract][Full Text] [Related]
20. Sex and Race Differences in Lifetime Risk of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction. Pandey A; Omar W; Ayers C; LaMonte M; Klein L; Allen NB; Kuller LH; Greenland P; Eaton CB; Gottdiener JS; Lloyd-Jones DM; Berry JD Circulation; 2018 Apr; 137(17):1814-1823. PubMed ID: 29352072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]